202 related articles for article (PubMed ID: 32361589)
1. The role of epithelial-mesenchymal transition in regulating radioresistance.
Zhou S; Zhang M; Zhou C; Wang W; Yang H; Ye W
Crit Rev Oncol Hematol; 2020 Jun; 150():102961. PubMed ID: 32361589
[TBL] [Abstract][Full Text] [Related]
2. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
Yao YH; Cui Y; Qiu XN; Zhang LZ; Zhang W; Li H; Yu JM
Chin J Cancer; 2016 Jun; 35():50. PubMed ID: 27266881
[TBL] [Abstract][Full Text] [Related]
3. The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.
Nantajit D; Lin D; Li JJ
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1697-713. PubMed ID: 25270087
[TBL] [Abstract][Full Text] [Related]
4. Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.
Choi YJ; Baek GY; Park HR; Jo SK; Jung U
PLoS One; 2016; 11(1):e0147343. PubMed ID: 26799321
[TBL] [Abstract][Full Text] [Related]
5. The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma.
Zhang H; Si J; Yue J; Ma S
J Cancer Res Clin Oncol; 2021 May; 147(5):1275-1286. PubMed ID: 33687564
[TBL] [Abstract][Full Text] [Related]
6. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.
Marie-Egyptienne DT; Lohse I; Hill RP
Cancer Lett; 2013 Nov; 341(1):63-72. PubMed ID: 23200673
[TBL] [Abstract][Full Text] [Related]
8. IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma.
Zang C; Liu X; Li B; He Y; Jing S; He Y; Wu W; Zhang B; Ma S; Dai W; Li S; Peng Z
Oncotarget; 2017 Feb; 8(7):11228-11238. PubMed ID: 28061440
[TBL] [Abstract][Full Text] [Related]
9. Fractionated irradiation-induced EMT-like phenotype conferred radioresistance in esophageal squamous cell carcinoma.
Zhang H; Luo H; Jiang Z; Yue J; Hou Q; Xie R; Wu S
J Radiat Res; 2016 Jul; 57(4):370-80. PubMed ID: 27125498
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance.
Stark TW; Hensley PJ; Spear A; Pu H; Strup SS; Kyprianou N
Prostate; 2017 Dec; 77(16):1583-1591. PubMed ID: 29063620
[TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma.
Lu Y; Li T; Wei G; Liu L; Chen Q; Xu L; Zhang K; Zeng D; Liao R
Tumour Biol; 2016 Sep; 37(9):11733-11741. PubMed ID: 27020592
[TBL] [Abstract][Full Text] [Related]
12. HSP27 associates with epithelial-mesenchymal transition, stemness and radioresistance of salivary adenoid cystic carcinoma.
Chen W; Ren X; Wu J; Gao X; Cen X; Wang S; Sheng S; Chen Q; Tang YJ; Liang XH; Tang YL
J Cell Mol Med; 2018 Apr; 22(4):2283-2298. PubMed ID: 29424489
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs as critical regulators involved in regulating epithelial- mesenchymal transition.
Zhao X; Lu Y; Nie Y; Fan D
Curr Cancer Drug Targets; 2013 Nov; 13(9):935-44. PubMed ID: 24168189
[TBL] [Abstract][Full Text] [Related]
14. 2-Methoxyestradiol inhibits the proliferation and migration and reduces the radioresistance of nasopharyngeal carcinoma CNE-2 stem cells via NF-κB/HIF-1 signaling pathway inactivation and EMT reversal.
Wu SL; Li YJ; Liao K; Shi L; Zhang N; Liu S; Hu YY; Li SL; Wang Y
Oncol Rep; 2017 Feb; 37(2):793-802. PubMed ID: 28000883
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
van Staalduinen J; Baker D; Ten Dijke P; van Dam H
Oncogene; 2018 Nov; 37(48):6195-6211. PubMed ID: 30002444
[TBL] [Abstract][Full Text] [Related]
16. Is the epithelial-to-mesenchymal transition clinically relevant for the cancer patient?
Krasnapolski MA; Todaro LB; de Kier Joffé EB
Curr Pharm Biotechnol; 2011 Nov; 12(11):1891-9. PubMed ID: 21470129
[TBL] [Abstract][Full Text] [Related]
17. Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies.
Qiao L; Chen Y; Liang N; Xie J; Deng G; Chen F; Wang X; Liu F; Li Y; Zhang J
Front Oncol; 2022; 12():775238. PubMed ID: 35251963
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial pyruvate carrier 1 expression controls cancer epithelial-mesenchymal transition and radioresistance.
Takaoka Y; Konno M; Koseki J; Colvin H; Asai A; Tamari K; Satoh T; Mori M; Doki Y; Ogawa K; Ishii H
Cancer Sci; 2019 Apr; 110(4):1331-1339. PubMed ID: 30801869
[TBL] [Abstract][Full Text] [Related]
19. α-Actinin-4 confers radioresistance coupled invasiveness in breast cancer cells through AKT pathway.
Desai S; Barai A; Bukhari AB; De A; Sen S
Biochim Biophys Acta Mol Cell Res; 2018 Jan; 1865(1):196-208. PubMed ID: 29055790
[TBL] [Abstract][Full Text] [Related]
20. Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets.
Sato R; Semba T; Saya H; Arima Y
Stem Cells; 2016 Aug; 34(8):1997-2007. PubMed ID: 27251010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
